Bahrain Mumtalakat Holding Company, the investment arm of the Kingdom of Bahrain, has announced its successful acquisition of an equity stake in KOS Group, a leading European healthcare group focused on longterm care and rehabilitation services, with additional activities in hospital equipment management, diagnostics and cancer care services. This investment reflects Mumtalakat’s continued commitment to grow its portfolio across multiple sectors and geographies.

Founded in 2003, KOS Group is a healthcare group in Italy that operates in the area of social health, residential care for chronic illnesses, rehabilitation and mental health services, and management of medical equipment and diagnostic centres. It has over 77 dedicated facilities comprising of 7300 beds, including nursing homes, rehabilitation centres, hospitals, and mental health clinics. Additionally, the group has an international presence through its diagnostics & cancer care services unit in the UK and India. In 2015, KOS posted consolidated revenues of €439.2 million (US$491.6 million) and a net income of €19.8 million (US$22.2 million).

Mumtalakat’s investment was made indirectly through the purchase of an interest in F2i Healthcare, the vehicle company controlled by the F2i Second Fund in which other investors have interests, which has been a shareholder of KOS since May of this year. As part of the deal, CIR sold to F2i Healthcare 3.2% of KOS for an amount of approximately €20 million (US$22.4 million).

Following this transaction, the shareholding structure of KOS consists of CIR with 59.53% and F2i Healthcare with 40.47%. F2i remains the controlling shareholder of F2i Healthcare, with a stake of 61.4%.

The acquisition highlights Mumtalakat’s objective to invest in the healthcare sector, which is projected to steadily grow regionally and internationally. Mumtalakat aims to support KOS Group’s potential expansion into the Kingdom of Bahrain and the broader GCC market.

Commenting on this successful acquisition, Mr. Mahmood Hashim Alkooheji, Chief Executive Officer of Mumtalakat said:

“We are pleased to announce our investment in the healthcare sector in Europe. The healthcare sector has solid growth potential, and this transaction is aligned with our objectives to create a diversified, global portfolio and achieve sustainable investment returns. As a value adding, long-term partner, Mumtalakat aims to support KOS Group’s expansion initiatives as well as its plans to establish a foothold in the Kingdom, which will act as a platform to serve the high growth Post-Acute Care sector in the GCC.”